by Frank Otto, Perelman School of Medicine at the University of Pennsylvania Credit: Unsplash/CC0 Public Domain Although the prevalence of diabetes-related eye diseases has almost doubled since 2014, the rates of the most severe forms of the disease have actually decreased, according to a new study led by researchers at the Perelman School of Medicine at...
Tag: <span>Diabetes</span>
Post
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
by Stephanie Brown The U.S. Food and Drug Administration has approved Sanofi-Aventis’s Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus. Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA. Administering Merilog subcutaneously five to 10 minutes before...
Post
Mitochondria’s role in diabetes: Could reversing damage offer a cure?
by Ananya Sen, University of Michigan Credit: Pixabay/CC0 Public Domain Mitochondria are essential for generating energy that fuels cells and helps them function. Mitochondrial defects, however, are associated with the development of diseases such as type 2 diabetes. Patients who suffer from this disorder are unable to produce enough insulin or use the insulin produced by...
Post
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
by Matthew Perrone A U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md., on Aug. 2, 2018. Credit: AP Photo/Jacquelyn Martin, File Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications needed...
Post
Q&A: Transplant treatment for diabetes shows promising results
by Annica Hulth, Uppsala University Per-Ola Carlsson, Professor of Medical Cell Biology. Credit: Mikael Wallerstedt A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered transplants of genetically modified insulin-producing cells and the initial results are promising. We put a few questions to Per-Ola Carlsson, Professor...
Post
New animal model offers insights into pancreatic disease and diabetes
by First Hospital of Jilin University Representative histological sections of the pancreas of rabbits with cystic fibrosis (CF). Credit: eGastroenterology (2024). DOI: 10.1136/egastro-2024-100102 Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and often overlooked complication. A recent study published in eGastroenterology introduces young rabbits with CF as a novel and accessible...
Post
Enzyme G6PC2’s role in regulating blood sugar levels offers new diabetes insights
by Hebrew University of Jerusalem Credit: Pixabay/CC0 Public Domain A new study has uncovered a critical role for the enzyme Glucose-6-phosphatase 2 (G6PC2) in regulating blood sugar levels. The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research, published in Science...
Post
Continuous glucose monitors rival A1c in predicting diabetes complications
by University of Virginia Credit: Pixabay/CC0 Public Domain Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of Virginia Center for Diabetes Technology researchers have found. That suggests doctors may be able to use data from the devices to help save patients from blindness, diabetic neuropathy and...
Post
Recommendations for Managing Diabetes and Cardiorenal and Metabolic Diseases (International Consensus Group, 2024)
International Consensus Group These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference. December 04, 2024 1 41 Share Added to Email Alerts A clinical guideline update on the management of diabetes as well as cardiorenal and metabolic diseases...
Post
GLP-1 RAs efficacious for weight loss in overweight, obesity without diabetes
by Elana Gotkine For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine. Areesha Moiz, from McGill University in Montreal, and colleagues examined the efficacy and safety of GLP-1 RAs and co-agonists for obesity treatment among adults...